GH Research PLC — Cash Flow (NASDAQ:GHRS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 15.28 M26.2 M33.34 M42.28 M43.55 M — Cash from investing activities -104 K84.69 M54.1 M65.14 M46.17 M — Cash from financing activities 286.45 M0204 K304 K139.65 M — Free cash flow 15.28 M26.2 M33.34 M42.28 M43.55 M —

News

Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?

GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3

Guggenheim raises GH Research stock price target to $34 on trial data

Needham raises GH Research stock price target to $32 on phase 3 plans

Citizens raises GH Research stock price target on phase 3 progress

GH Research reports Phase 2b trial results for depression treatment

GH Research stock price target raised to $40 from $33 at RBC Capital

Eli Lilly and Regencell among market cap stock movers on Wednesday

GH Research stock price target raised to $29 from $19 at Needham

GH Research stock jumps as Canaccord raises price target on FDA hold lift

GH Research stock rises as FDA lifts clinical hold on GH001

Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug